Petco Health & Wellness Company, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Petco Health & Wellness Company, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2021	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	4,435	4,920	5,807	6,036	6,255	6,116	5,961
Cost of revenue	2,528	2,813	3,381	3,609	3,901	3,792	3,656
Gross profit	1,907	2,107	2,427	2,427	2,354	2,324	2,305
Selling, general and administrative	1,777	1,912	2,161	2,202	2,312	2,317	2,185
Selling and marketing				204	194	156	158
Operating income	111	194	266	226	-1,180	7.05	120
Interest expense	253	219	77.4	102	151	144	131
Interest income	0.34	0.65	0.06	1.03	3.41	3.71	6.31
Other non-operating income			34.5	-12.7	4.73	4.8	0
Pre-tax income	-142	-41.6	202	112	-1,308	-109	15.3
Income tax	-35.7	-3.34	53.5	35.3	-27.6	-7.48	6.27
Net income to minority interests	-8.11	-5.25	-4.61	-0.89	0	0
Net income	-95.9	-26.5	164	90.8	-1,280	-102	9.07
EBITDA	284	369	439	419	-977	216	317
EPS, basic	-0.46	-0.13	0.62	0.34	-4.78	-0.37	0.03
EPS, diluted	-0.46	-0.13	0.62	0.34	-4.78	-0.37	0.03
Shares, basic (weighted)	0.21	0.21	0.26	266	268	273	280
Shares, diluted (weighted)	0.21	0.21	0.27	266	268	273	286

Balance sheet

	FY2021	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	155	111	212	202	125	166	257
Receivables		41.8	55.6	49.6	44.4	40.4	45.8
Inventory		539	675	652	685	653	590
Other current assets		45.6	86.1	60.8	38.8	60.6	75.3
Total current assets		778	1,071	1,016	952	974	1,020
Property, plant and equipment		628	727	803	816	725	656
Lease right-of-use assets		1,328	1,338	1,398	1,384	1,302	1,289
Goodwill	2,179	2,179	2,184	2,194	980	980	980
Intangible assets		0.71
Other non-current assets		138	153	177	206	188	204
Total assets		6,076	6,498	6,613	5,363	5,194	5,173
Accounts payable		339	404	381	485	493	451
Accrued liabilities		146	211	218	200	177	205
Deferred revenue		15.5	18	23	33.5	29.6	31.4
Short-term debt		2.2	21.8	22.8	16	5.35	4.61
Total current liabilities		875	1,053	1,021	1,113	1,139	1,134
Long-term debt		1,646	1,640	1,628	1,576	1,578	1,489
Lease liabilities		1,084	1,096	1,148	1,117	1,037	1,047
Other non-current liabilities		134	134	130	121	109	104
Total liabilities		4,020	4,242	4,231	4,179	4,081	4,009
Total debt		1,646	1,640	1,628	1,576	1,578	1,489
Paid-in capital		2,092	2,134	2,152	2,230	2,280	2,312
Retained earnings		-22.3	142	233	-1,047	-1,149	-1,140
Other comprehensive income		-1.28	-2.24	-4.1	1.82	-18.1	-8.39
Shareholders' equity		2,069	2,274	2,381	1,184	1,114	1,164
Minority interests		-13.6	-18.2
Total equity	561	2,055	2,256	2,381	1,184	1,114	1,164
Total liabilities and equity		6,076	6,498	6,613	5,363	5,194	5,173

Cash flow statement

	FY2021	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-104	-31.7	160	89.9	-1,280	-102	9.07
Depreciation and amortization	174	175	172	194	204	209	197
Stock-based compensation	9.49	12.9	49.3	60.8	81.9	50.2	32.7
Deferred income tax	-45.1	25.5	37.7	-0.89	-53.5	-30.5	17.1
Change in receivables	-3.85	-10.3	-13.8	6.04	5.21	4.18	-5.62
Change in inventory	-8.19	-60.6	-136	22.7	-32.1	30.8	63.1
Change in payables	15.9	46.3	71.8	-22.8	104	8.48	-43
Cash from operations	110	269	358	346	216	178	314
Capital expenditures	-157	-160	-239	-278	-226	-128	-127
Acquisitions	-2.81		-4.33	-9.64	-6.73	-0.63
Purchases of investments	-0.59	-1
Cash from investing	-139	-157	-237	-320	-207	-124	-125
Debt issued	1,297	476	1,700	123	273	201
Debt repaid	-1,293	-1,555	-1,691	-140	-348	-201	-95.3
Stock issued						2.5
Share buybacks		-0.11
Cash from financing	-3.07	-147	-18.8	-33.8	-85.4	-8.75	-102
Net change in cash	-31.8	-35.2	102	-8.16	-77.1	45	87.7
Free cash flow	-46.6	109	119	68	-9.88	49.7	187
Interest paid	218	179	64.5	89.3	142	139	125
Income taxes paid	15	2.39	16.1	14.4	32.2	34.8	5.83

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $2.27 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	38.8%	Gross profit / revenue.
Operating margin	2.2%	Operating income / revenue.
EBITDA margin	5.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-0.0%	Pre-tax income / revenue.
Net margin	0.5%	Net income / revenue.
FCF margin	4.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.3%	Cash from operations / revenue.
Return on equity (ROE)	2.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.6%	Net income / average total assets.
Return on invested capital (ROIC)	11.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	36.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.3%	Capital expenditures / revenue.
D&A / revenue	3.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-0.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-1.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	1,608.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-18.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-9.1%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	47.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-8.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-3.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y	-53.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 3y	-55.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	76.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-3.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	3.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	276.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	40.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	11.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	4.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-21.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-10.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-7.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-3.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	4.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	323.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.90x	Current assets / current liabilities.
Quick ratio	0.28x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.25x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.01x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	0.2%	Total debt / total assets.
Liabilities / assets	76.6%	Total liabilities / total assets.
Net debt	-$281.4M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.85x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	1.03x	Operating income / interest expense.
Working capital	-$113.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	19.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$226.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.15x	Revenue / average total assets.
Fixed asset turnover	9.46x	Revenue / average property, plant and equipment.
Inventory turnover	6.07x	Cost of revenue / average inventory.
Days inventory	60 days	365 x average inventory / cost of revenue.
Receivables turnover	155x	Revenue / average receivables.
Days sales outstanding	2 days	365 x average receivables / revenue.
Days payables	46 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	17 days	Days inventory + days sales outstanding - days payables.
FCF conversion	785.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	36.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.10	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$20.54	Revenue / diluted weighted shares.
FCF per share	$0.82	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.29	Cash from operations / diluted weighted shares.
Book value per share	$4.15	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.78	Tangible book value / shares outstanding.
Cash per share	$1.01	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$734.0M	Share price x shares outstanding.
Enterprise value	$452.6M	Market cap + total debt - cash - short-term investments.
P/E	24.2x	Market cap / net income. Only when net income is positive.
P/S	0.12x	Market cap / revenue.
P/B	0.61x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.24x	Market cap / tangible book value, when positive.
P/FCF	3.09x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	1.96x	Market cap / cash from operations, when positive.
EV/Sales	0.08x	Enterprise value / revenue.
EV/EBIT	3.39x	Enterprise value / operating income, when both are positive.
EV/EBITDA	1.37x	Enterprise value / EBITDA, when both are positive.
EV/FCF	1.90x	Enterprise value / free cash flow, when both are positive.
FCF yield	32.4%	Free cash flow / market cap.
Earnings yield	4.1%	Net income / market cap (the inverse of P/E).

What was Petco Health & Wellness Company, Inc.'s revenue in fiscal 2025?

Petco Health & Wellness Company, Inc. reported revenue of $5.96B for fiscal 2025, 2.5% lower than the year before.

Was Petco Health & Wellness Company, Inc. profitable in fiscal 2025?

Yes. Net income was $9.1M, a net margin of 0.2%.

How much free cash flow did Petco Health & Wellness Company, Inc. generate in fiscal 2025?

Cash from operations of $314.1M minus capital expenditures of $127.1M left free cash flow of $187.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Petco Health & Wellness Company, Inc.